CTLA4 and hepatocellular carcinoma: Consistent with our findings, the expression of MLKL in HCC was highly correlated with expression of multiple immune checkpoints including PD-1, CTLA-4, TIGIT, TIM3 and LAG3, suggesting the associated immune tolerance in MLKL-high expression tumors (Fig. 2i).